Navigation Links
Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S.
Date:3/16/2011

FARMINGDALE, N.Y., March 16, 2011 /PRNewswire/ -- Misonix, Inc. (Nasdaq: MSON), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, has announced a definitive agreement for non-exclusive distribution, with the exception of certain selected accounts, of the BoneScalpel Ultrasonic Bone Cutting System in the United States with Aesculap, Inc., which replaces a prior exclusive distribution agreement between the parties.  The agreement is limited to clinical applications relative to the spine and cranium.

In response, Misonix will begin the marketing, sales, distribution and service of the BoneScalpel in the U.S., effective immediately, utilizing its 75 person surgical sales organization, which markets direct to hospitals and free-standing surgery centers.  In addition to spine and cranial applications, the Misonix sales organization will market the product for a broad range of maxiofacial and other small bone clinical applications.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.  It offers the convenience and speed of a power instrument while minimizing the peril associated with rotary sharps.

"Misonix is excited about adding BoneScalpel to our focused, domestic sales organization.  With this Agreement, Misonix will now be selling the BoneScalpel worldwide," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.  "Over time, we anticipate significant margin improvement and sales growth by allowing our proprietary sales organization the opportunity to sell another one of our key products under t
'/>"/>

SOURCE Misonix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Misonix to Present at the ROTH Capital Growth Stock Conference on March 15, 2011
2. Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results
3. Misonix Announces Completion of Product Registrations in Key Latin American Markets
4. Misonix Schedules Second Quarter 2011 Financial Results Conference Call; February 9, 2011 at 4:30 p.m. Eastern
5. Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
6. Misonix Announces Achievement of Contract Vendor Status With Select Medical Corporation
7. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
8. Misonix Reports First Quarter Fiscal 2011 Financial Results
9. Misonix Announces New Distribution Agreement for South Africa
10. Misonix Schedules First Quarter 2011 Financial Results Conference Call; November 15, 2010 at 4:30 P.M. Eastern
11. Misonix Announces Change in Distribution of SonaStar® Surgical Aspiration System in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- Pomerantz LLP is investigating claims on behalf of investors ... VTAE ).  Such investors are advised to ... or 888-476-6529, ext. 237. The investigation ... directors have violated Sections 10(b) and 20(a) of the ... February 27, 2015, the Company announced that its partner ...
(Date:2/27/2015)... Securities lawyers at Dunnam & Dunnam ... (NASDAQ: SLXP ) in connection with a ... are encouraged to contact attorney Hamilton Lindley by ... upon the shareholder value of the transaction. Under terms ... $158.00 per share in cash. At least one analyst ...
(Date:2/27/2015)... 2015 Report Details   ... trends, R&D progress, and predicted revenues ,Where is the ... the commercial prospects for this market and related technologies? ... other trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
...  Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced ... for the quarter ended December 31, 2011, on Thursday, February ... press release announcing the results for the quarter ended December ... February 8, 2012 after the close of the market. A ...
... DIEGO, Jan. 9, 2012 Amylin Pharmaceuticals, Inc. (Nasdaq: ... 2012, with a strong focus on driving the global commercial ... at the 30th Annual J.P. Morgan Healthcare Conference in San ... highlighted steps the company is taking to prepare for the ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Fourth Quarter 2011 Earnings Release Conference Call 2Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates 2Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates 3Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates 4
(Date:3/1/2015)... 01, 2015 A federal court ... ) scheduled to go to trial in October ... witness to provide testimony regarding the role an ... the Profemur device, Bernstein Liebhard LLP comments. According ... Northern District of Iowa on February 25th, Wright ...
(Date:3/1/2015)... 01, 2015 “ The Barrel Mill ” ... Report, which takes a look at the latest and coolest ... host of NewsWatch and a technology expert, conducted the review ... flavor to drinks. , According to Home Distillation of Alcohol, ... spirits. Well, there’s a pretty cool product that’ll help anyone ...
(Date:2/28/2015)... Heart diseases are on the rise ... urban adult population and 5 percent of rural adult ... 20-30 percent of them require specialized investigation and treatment ... vascular diseases (CVD). , A division of Indian Business ... report titled “Indian Coronary Stent Market Forecast to 2019”. ...
(Date:2/28/2015)... February 28, 2015 The Classic ... offering a new special. Throughout all of March ... , This service can help overall ... and pain. Patients may notice certain symptoms that suggest ... These symptoms include: , 1.    Pain, clicking, and popping ...
(Date:2/28/2015)... A study out of the University of ... for the treatment of a hereditary ocular condition that ... by Dr. Robert MacLaren, professor of ophthalmology at the ... Journal on January 16, 2014 , the study treated ... that mostly affects men and leads to the degeneration ...
Breaking Medicine News(10 mins):Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2
... only a few basic ways to fight viruses. A vaccine can ... invade the body//. If a virus manages to establish itself, a ... its spread. And if all else fails, a doctor may quarantine ... scientists are exploring a fundamentally different strategy to fight viruses. They ...
... Trusts have welcomed a move to bring an end to the ... ,Till now, when a health trust falls into deficit, ... debts but in addition, some money is cut off from its ... this has meant that some health trusts find it virtually impossible ...
... provide detailed information on how well a transplanted heart ... as the Allomap test, is currently used to detect ... invasive heart muscle biopsies, but has now been shown ... the heart before pumping, and the electrical properties of ...
... the popular anti-clotting drug clopidogrel (Plavix) when taken along with ... adverse bleeding event.// ,The study, to be ... Session on March 27 at 9 am (abstract 1027-18), found ... worsen bleeding after off-pump heart bypass surgery. ...
... children, yet the number of pediatric orthopedists trained to ... decreasing nationwide. The management of fractures in children is ... is needed to provide the best care for these ... for Special Surgery (HSS). ,Fractures in ...
... of Indian MPs has come together to launch a fight ... start a massive awareness drive and also seeking a special ... that at least two people die of the infectious disease ... have decided to form a group next month and to ...
Cached Medicine News:Health News:Scientists Explore Ways to Lure Viruses to Their Death 2Health News:Scientists Explore Ways to Lure Viruses to Their Death 3Health News:Double-penalty System for Bankrupt Health Trusts Lifted 2Health News:Gene Test Shown to Measure Heart Function After Transplant 2Health News:Plavix Safe During and After Heart Bypass 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 2Health News:Number of Specialists Best at Treating Children's Fractures Decreasing 3Health News:Indian Parliamentarians Join to Fight Against TB 2
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: